The next 5 years: Where Dr. Todd Chapman sees the biggest opportunities for new spine surgeons | SI-Bone files $98M IPO: 4 things to know | Don’t miss out on 100+ informative sessions at the Becker’s 25th Annual Meeting |…
Spine Review
Medtronic adds to spine business with $1.64B acquisition of Mazor: 6 things to know | Texas pain physician faces 10 years in prison for alleged healthcare fraud: 5 takeaways | Learn about key ASC trends at the Becker’s ASC 25th…
Orthopedic surgeon in Calif. arrested for allegedly drugging, assaulting women: 5 things to know | The biggest challenges in spine reimbursement and the value-based solution | The best ideas for ASCs today – Reg for the Becker’s ASC 25th Annual…
Why private equity deals will become more common for orthopedic practices | 18 spine devices receive FDA clearance in August | The best ideas for ASCs today – learn more at the Becker’s ASC 25th Annual Meeting | Sutter Health…
Dr. Michael Verdon: Where data analytics, precision medicine will take spine surgery | Globus Medical makes acquisition to complement its spinal navigation business: 5 things to know | Learn about the best specialties for ASCs, staffing trends, reimbursement & more…
Dr. Dennis Crandall: 7 exciting areas of spine tech development + considerations for value-based care | Former orthopedic clinic employee allegedly wrote 100+ pain med prescriptions for herself: 5 things to know | How to approach ASC rev cycle challenges,…
Spine tech adoption in a value-based practice – What’s worth the investment? 3 Qs with Dr. Jesse Even | Benvenue Medical to focus on MIS spine, divests vertebral augmentation systems: 5 key notes | What are the biggest opportunities for…
Rothman Orthopaedic Institute adds 5 NY-based surgeons to new NJ location: 5 things to know | The best opportunity to show value in spine: 4 surgeons on bundled payments | Join 1,500 attendees at the Becker’s ASC 25th Annual Meeting…
Johnson & Johnson Medical Device Companies acquires German spine co.: 5 insights | Spinal biologics market to exceed $2.6B by 2022: 3 observations | The biggest topics for ASCs today from 175 expert speakers – don’t miss the Becker’s ASC…
Stryker to purchase Invuity for $190M in 2nd acquisition deal in 2 weeks: 5 things to know | Dr. Choll Kim: Biologics holds great promise for spine surgery | 175 ASC industry speakers at the Becker’s ASC 25th Annual Meeting…
